RMED RSI Chart
Last 7 days
0.5%
Last 30 days
-15.7%
Last 90 days
-49.5%
Trailing 12 Months
-93.3%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 450.5K | 0 | 0 | 0 |
2023 | 90.0K | 204.0K | 337.0K | 453.5K |
2022 | 28.0K | 24.0K | 19.0K | 14.0K |
2021 | 1.8M | 1.2M | 602.0K | 22.0K |
2020 | 1.5M | 1.8M | 2.1M | 2.3M |
2019 | 7.0M | 8.0M | 7.8M | 1.3M |
2018 | 6.0M | 6.1M | 6.2M | 6.3M |
2017 | 0 | 0 | 0 | 5.9M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 23, 2023 | meline susanne | acquired | - | - | 2,575 | - |
Mar 23, 2023 | caruso james joseph | acquired | - | - | 1,779 | - |
Mar 23, 2023 | jenkins david a | acquired | - | - | 277,597 | ex. chairman of the board |
Mar 23, 2023 | jenkins david a | acquired | - | - | 711,967 | ex. chairman of the board |
Nov 20, 2022 | mcguire jonathan will | sold (taxes) | -224 | 2.67 | -84.00 | ceo & secretary |
May 20, 2022 | mcguire jonathan will | sold (taxes) | -1,277 | 0.3013 | -4,241 | chief executive officer |
May 20, 2022 | jackson andrew c. | sold (taxes) | -410 | 0.3013 | -1,361 | cfo |
Nov 22, 2021 | mcguire jonathan will | sold | -21,350 | 2.62 | -8,149 | chief executive officer |
Nov 22, 2021 | jackson andrew c. | sold | -7,032 | 2.62 | -2,684 | cfo |
Nov 20, 2021 | jackson andrew c. | back to issuer | - | - | -11,759 | cfo |
Which funds bought or sold RMED recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | Federation des caisses Desjardins du Quebec | new | - | 194 | 194 | -% |
May 15, 2024 | ARMISTICE CAPITAL, LLC | added | 155 | 203,651 | 302,004 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 2.53 | 714 | 3,776 | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | new | - | 5,451 | 5,451 | -% |
May 14, 2024 | Qube Research & Technologies Ltd | unchanged | - | 1.00 | 3.00 | -% |
May 14, 2024 | Baird Financial Group, Inc. | unchanged | - | 8,218 | 48,883 | -% |
May 13, 2024 | GEODE CAPITAL MANAGEMENT, LLC | unchanged | - | 2,409 | 14,328 | -% |
May 13, 2024 | Key Financial Inc | unchanged | - | - | 1.00 | -% |
May 13, 2024 | UBS Group AG | reduced | -2.95 | 724 | 5,044 | -% |
May 13, 2024 | RENAISSANCE TECHNOLOGIES LLC | sold off | -100 | -10,000 | - | -% |
Unveiling Ra Medical Systems, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Ra Medical Systems, Inc. News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -29.6% | 82,000 | 116,500 | 133,000 | 119,000 | 85,000 | - | - | 5,000 | 9,000 | 5,000 | 5,000 | 9,000 | 4,500 | - | 68,000 | 900,000 | 1,374,000 | 1,641,000 | 1,908,000 | 2,153,000 | 1,748,000 |
Cost Of Revenue | -28.6% | 5,000 | 7,000 | 6,000 | 7,000 | 10,000 | - | - | 66,000 | 95,000 | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | -36.4% | 77,000 | 121,000 | 127,000 | 89,000 | 75,000 | - | - | -61,000 | -86,000 | -342,500 | -241,000 | -511,000 | -443,000 | -681,000 | -500,000 | -267,000 | -210,000 | -1,569,000 | -517,000 | -580,000 | -194,000 |
Operating Expenses | -0.9% | 2,693,000 | 2,718,000 | 2,857,000 | 6,397,000 | 66,559,000 | 8,215,000 | 4,783,000 | 8,399,000 | 5,417,000 | 7,921,500 | 7,153,000 | 6,227,000 | 6,427,000 | 9,426,000 | 7,007,000 | 9,849,000 | 7,580,000 | 3,148,000 | 17,071,000 | 14,768,000 | 14,760,000 |
S&GA Expenses | -2.7% | 2,656,000 | 2,729,000 | 2,745,000 | 1,415,000 | 10,233,000 | 7,958,000 | 3,514,000 | 2,476,000 | 2,302,000 | 4,189,500 | 4,211,000 | 3,398,000 | 3,677,000 | 6,018,000 | 4,695,000 | 7,896,000 | 6,285,000 | 2,395,000 | 15,889,000 | 13,789,000 | 13,229,000 |
R&D Expenses | 436.4% | 37,000 | -11,000 | 112,000 | 134,000 | 240,000 | 154,000 | 727,000 | 2,396,000 | 3,115,000 | 3,732,000 | 2,942,000 | 2,829,000 | 2,750,000 | 3,408,000 | 2,312,000 | 1,953,000 | 1,295,000 | 753,000 | 1,182,000 | 979,000 | 1,531,000 |
EBITDA Margin | -2.3% | -154 | -150 | -226 | -390 | -954 | -1,888 | -1,385 | -1,193 | -878 | -1,165 | -45.01 | -22.93 | -18.41 | -14.16 | - | - | - | - | - | - | - |
Interest Expenses | -50.0% | 3,000 | 6,000 | - | 17,000 | 181,000 | - | - | - | - | -40,500 | - | 31,000 | 52,000 | -6,000 | 5,000 | 15,000 | 25,000 | -115,000 | 72,000 | 66,000 | 48,000 |
Income Taxes | - | - | - | - | - | - | 3,000 | - | - | - | 2,000 | - | - | - | - | - | - | - | 7,000 | 3,000 | 5,000 | - |
Earnings Before Taxes | 100.0% | - | -669,000 | -1,927,000 | -1,576,000 | -66,400,000 | -8,156,000 | -4,763,000 | -8,448,000 | -5,495,000 | -8,283,000 | -7,378,000 | -4,719,000 | -6,877,000 | -10,105,500 | -7,515,000 | -10,121,000 | -7,701,000 | -4,434,000 | -17,415,000 | -15,117,000 | -14,674,000 |
EBT Margin | -0.7% | -156 | -155 | -231 | -396 | -975 | -1,918 | -1,420 | -1,233 | -924 | -1,238 | -48.30 | -24.72 | -19.65 | -15.13 | - | - | - | - | - | - | - |
Net Income | -299.9% | -2,675,000 | -669,000 | -1,927,000 | -1,576,000 | -66,400,000 | -8,159,000 | -4,763,000 | -8,448,000 | -5,495,000 | -8,287,000 | -4,298,000 | -5,249,000 | -7,236,000 | -10,444,000 | -7,779,000 | -10,121,000 | -7,701,000 | -9,743,000 | -17,418,000 | -15,122,000 | -14,674,000 |
Net Income Margin | 90.2% | -15.20 | -155 | -231 | -396 | -975 | -1,918 | -1,420 | -1,105 | -833 | -1,139 | -45.23 | -25.98 | -20.19 | -15.39 | - | - | - | - | - | - | - |
Free Cashflow | -3.0% | -1,964,000 | -1,907,000 | -1,831,000 | -4,867,000 | -12,090,000 | -3,042,000 | -4,966,000 | -6,008,000 | -8,569,000 | -5,752,000 | -7,363,000 | -6,677,000 | -8,098,000 | -9,409,000 | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -8.8% | 28,021 | 30,736 | 32,871 | 35,542 | 48,509 | 16,836 | 17,471 | 14,373 | 23,747 | 21,044 | 27,079 | 29,159 | 25,262 | 33,438 | 43,454 | 40,691 | 36,300 | 44,081 | 54,002 | 62,474 | 69,280 |
Current Assets | -53.0% | 1,954 | 4,161 | 5,776 | 7,908 | 12,756 | 16,836 | 15,542 | 12,332 | 20,014 | 17,089 | 22,799 | 24,077 | 19,918 | 27,620 | 37,179 | 33,779 | 28,689 | 36,000 | 45,452 | 53,488 | 60,453 |
Cash Equivalents | -58.2% | 1,491 | 3,565 | 5,579 | 7,410 | 12,218 | 15,859 | 13,657 | 11,128 | 17,652 | 15,045 | 20,616 | 20,220 | 15,954 | 23,906 | 33,646 | 29,380 | 18,437 | 14,584 | 14,512 | 11,787 | 55,129 |
Inventory | 43.2% | 63.00 | 44.00 | 64.00 | 59.00 | 70.00 | - | - | 43.00 | 1,059 | 986 | 997 | 2,323 | 2,249 | 877 | 2,592 | 2,704 | 2,773 | 1,292 | 2,572 | 2,344 | 2,217 |
Net PPE | 15.7% | 81.00 | 70.00 | 59.00 | 67.00 | 56.00 | - | - | 38.00 | 1,658 | 1,809 | 2,030 | 2,661 | 2,820 | 2,527 | 3,581 | 4,106 | 4,687 | 4,144 | 5,418 | 5,767 | 5,530 |
Liabilities | -0.5% | 9,497 | 9,543 | 11,004 | 11,751 | 12,646 | 7,576 | 4,961 | 4,582 | 5,639 | 7,371 | 5,530 | 7,896 | 10,117 | 12,291 | 12,916 | 13,707 | 9,826 | 10,931 | 12,261 | 10,579 | 9,483 |
Current Liabilities | -4.9% | 2,350 | 2,472 | 2,035 | 2,042 | 4,453 | 7,576 | 3,215 | 2,754 | 3,735 | 5,390 | 3,476 | 5,205 | 5,979 | 7,762 | 8,039 | 8,304 | 6,022 | 6,814 | 7,982 | 6,295 | 5,085 |
Shareholder's Equity | -12.6% | 18,524 | 21,193 | 21,867 | 23,791 | 35,863 | 9,260 | 12,510 | 9,791 | 18,108 | 13,673 | 21,549 | 21,263 | 15,145 | 21,147 | 30,538 | 26,984 | 26,474 | 33,150 | 41,741 | 51,895 | 59,797 |
Retained Earnings | -1.0% | -278,384 | -275,709 | -275,040 | -273,113 | -271,537 | -205,137 | -196,978 | -192,215 | -183,767 | -178,272 | -169,985 | -165,687 | -160,438 | -153,202 | -142,758 | -134,979 | -124,858 | -117,157 | -107,414 | -89,996 | -74,874 |
Additional Paid-In Capital | 0.0% | 296,907 | 296,901 | 296,906 | 296,904 | 307,400 | 214,397 | 209,488 | 201,996 | 201,865 | 191,945 | 191,527 | 186,943 | 175,576 | 174,342 | 173,289 | 161,959 | 151,327 | 150,280 | 149,116 | 141,839 | 134,670 |
Shares Outstanding | 7.8% | 7,573 | 7,027 | 7,008 | 5,368 | 5,267 | 2,161 | 68,200 | - | 629 | 140 | 141 | 118 | 65.00 | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 4,000 | - | - | - | 9,900 | - | - | - | 24,100 | - | - | - | 18,500 | - | - | - | 29,800 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -2.8% | -1,942 | -1,889 | -1,830 | -4,847 | -12,053 | -3,025 | -4,966 | -6,008 | -8,569 | -5,711 | -7,215 | -6,621 | -8,078 | -9,414 | -6,047 | -5,800 | -7,043 | -9,572 | -7,854 | -6,803 | -8,944 |
Share Based Compensation | 220.0% | 6.00 | -5.00 | 2.00 | -174 | 1,394 | 82.00 | 136 | 3.00 | 165 | 653 | 5.00 | 27.00 | 1,169 | -22,013 | 48,000 | 100 | 1,047 | 8,144 | 400 | 500 | 7,745 |
Cashflow From Investing | -22.2% | -22.00 | -18.00 | -1.00 | -20.00 | -22.00 | 21.00 | - | - | - | -1.00 | 3,345 | 169 | 289 | 5.00 | -23.00 | 4,979 | 10,972 | 9,952 | 10,673 | -36,492 | -165 |
Cashflow From Financing | -2.8% | -110 | -107 | - | 59.00 | 8,434 | 5,206 | 7,495 | -516 | 11,176 | 141 | 4,266 | 10,718 | -163 | -331 | 10,336 | 11,764 | -76.00 | -308 | -94.00 | -47.00 | -77.00 |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Condensed Consolidated Statements of Operations (Unaudited) | ||
Revenue | $ 82 | $ 85 |
Cost of revenues | 5 | 10 |
Gross profit | 77 | 75 |
Operating expenses | ||
Loss on impairment of goodwill | 0 | 56,086 |
Selling, general and administrative | 2,656 | 10,233 |
Research and development | 37 | 240 |
Total operating expenses | 2,693 | 66,559 |
Operating loss | (2,616) | (66,484) |
Other income (expense), net | ||
Interest income | 30 | 69 |
Other income (expense), net | (3) | 15 |
Change in fair value of royalties payable | (86) | 0 |
Total other income (expense), net | (59) | 84 |
Net loss | (2,675) | (66,400) |
Deemed dividend - warrant inducement offer | 0 | (800) |
Net loss attributable to common stockholders | $ (2,675) | $ (67,200) |
Net loss per share attributable to common stockholders, basic and diluted | $ (0.36) | $ (24.65) |
Weighted average common shares used in computing net loss per share, basic and diluted | 7,429,198 | 2,726,442 |
Condensed Consolidated Balance Sheets - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current Assets | ||
Cash and cash equivalents | $ 1,491,000 | $ 3,565,000 |
Accounts receivable | 73,000 | 137,000 |
Inventories | 63,000 | 44,000 |
Prepaid expenses and other current assets | 327,000 | 415,000 |
Total current assets | 1,954,000 | 4,161,000 |
Property and equipment, net | 81,000 | 70,000 |
Lease right-of-use assets | 171,000 | 179,000 |
Intangible assets, net | 25,807,000 | 26,318,000 |
Other non-current assets | 8,000 | 8,000 |
TOTAL ASSETS | 28,021,000 | 30,736,000 |
Current Liabilities | ||
Accounts payable | 543,000 | 464,000 |
Accrued expenses | 1,640,000 | 1,733,000 |
Notes payable | 74,000 | 184,000 |
Current portion of operating lease liabilities | 93,000 | 91,000 |
Total current liabilities | 2,350,000 | 2,472,000 |
Royalties payable | 7,060,000 | 6,974,000 |
Operating lease liabilities | 87,000 | 97,000 |
Total liabilities | 9,497,000 | 9,543,000 |
Stockholders' Equity | ||
Common stock, $0.0001 par value, 300,000,000 shares authorized; 7,573,403 and 7,026,627 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 1,000 | 1,000 |
Additional paid-in capital | 296,907,000 | 296,901,000 |
Accumulated deficit | (278,384,000) | (275,709,000) |
Total stockholders' equity | 18,524,000 | 21,193,000 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | 28,021,000 | 30,736,000 |
Series A convertible preferred stocks [Member] | ||
Stockholders' Equity | ||
Preferred Stock, $0.0001 par value, 10,000,000 shares authorized Series A Convertible Preferred Stock, $0.0001 par value, 7,203 shares designated; 3,703 and 4,578 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 0 | 0 |
Series x convertible preferred stocks [Member] | ||
Stockholders' Equity | ||
Preferred Stock, $0.0001 par value, 10,000,000 shares authorized Series A Convertible Preferred Stock, $0.0001 par value, 7,203 shares designated; 3,703 and 4,578 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | $ 0 | $ 0 |